Recent advances in research on human aortic valve calcification

Journal of Pharmacological Sciences

Volumn 124, Issue 2, 2014, Pages 129-137

  Furukawa, Ken Ichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Aortic stenosis; Aortic valve; Drug therapy; Ectopic calcification; Stem cell

Indexed keywords

AORTA VALVE STENOSIS; ARTERY CALCIFICATION; CALCIFICATION; CAUSE OF DEATH; ENDOCARDIUM; HEART VALVE REPLACEMENT; HUMAN; MECHANICAL STRESS; MESENCHYMAL STEM CELL; PHYSICAL CHEMISTRY; REVIEW; RISK FACTOR; SEDIMENTATION; SUDDEN CARDIAC DEATH;

AORTIC VALVE; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; CYTOKINES; DRUG DISCOVERY; HUMANS; HYPERLIPIDEMIAS; HYPERPHOSPHATEMIA; I-KAPPA B KINASE; LIPOPROTEINS, LDL; MESENCHYMAL STROMAL CELLS; MOLECULAR TARGETED THERAPY; NF-KAPPA B; NITRIC OXIDE DONORS; OSTEOBLASTS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895538316     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13R05CR     Document Type: Review

References (84)

1. Akerström F, Barderas MG, Rodríguez-Padial L. Aortic stenosis: a general overview of clinical, pathophysiological and therapeutic aspects. Expert Rev Cardiovasc Ther. 2013;11: 239-250.
2. Dimitrow PP, Jawien M, Rajtar-Salwa R. Pharmacotherapy of aortic stenosis-success or failure? Curr Pharm Biotechnol. 2012;13: 2497-2502.
3. Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart. 2012;98 Suppl 4:iv7-iv13.
4. Lalmand J, Lalmand M. Aortic stenosis in the elderly: what to monitor, when and how to treat? The place of TAVI. Rev Med Brux. 2012;33: 283-290.
5. Furukawa KI. Current topics in pharmacological research on bone metabolism: molecular basis of ectopic bone formation induced by mechanical stress. J Pharmacol Sci. 2006;100: 201-204.
6. O'Neill WC, Koba A. Lomashvili. Recent progress in the treatment of vascular calcification. Kidney Int. 2010;78: 1232-1239.
7. New SE, Aikawa E. Cardiovascular calcification: an inflammatory disease. Circ J. 2011;75: 1305-1313.
8. Gerber HP, Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med. 2000;10: 223-228.
9. Skinner LJ, Conlon BJ, Hegarty S, O'Dwyer TP. Ectopic ossification in the parotid gland. Rev Laryngol Otol Rhinol (Bord). 2003;124: 243-245.
10. Ribeiro KC, Mattos EC, Werneck-de-Castro JP, Ribeiro VP, Costa-e-Sousa RH, Miranda A, et al. Ectopic ossification in the scar tissue of rats withmyocardial infarction. Cell Transplant. 2006;15: 389-397.
11. Furukawa KI. Pharmacological aspect of ectopic ossification in spinal ligament tissues. Pharmacol Ther. 2008;118: 352-358.
12. Kirsch T. Determinants of pathological mineralization. Curr Opin Rheumatol. 2006;18: 174-180.
13. Lemarié CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol. 2010;48: 433-439.
14. Sherif HM. Calcification of left-sided valvular structures: evidence of a pro-inflammatory milieu. J Heart Valve Dis. 2009;18: 52-60.
15. Balachandran K, Sucosky P, Jo H, Yoganathan AP. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am J Pathol. 2010;177: 49-57.
16. Chikwe J, Walther A, Pepper J. The surgical management of aortic valve disease. Br J Cardiol. 2003;10: 453-461.
17. Bouchard-Martel J, Roussel E, Drolet MC, Arsenault M, Couet J. Interstitial cells from left-sided heart valves display more calcification potential than from right-sided valves: an in-vitro study of porcine valves. J Heart Valve Dis. 2009;18: 421-428.
18. Wang P, Acker MA, Bilello M, Melhem ER, Stambrook E, Ratcliffe SJ, et al. Sex, aging, and preexisting cerebral ischemic disease in patients with aortic stenosis. Ann Thorac Surg. 2010;90: 1230-1235.
19. Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res. 2011;108: 1392-1412.
20. Hashimoto K. Comparison of Japanese valve surgery results with those in Europe and the USA. Nihon Geka Gakkai Zasshi. 2012;113:278-282. (text in Japanese with English abstract)
21. Toutouzas KP, Stathogiannis KE, Latsios GS, Synetos AG, Stefanadis CI. Recent valves used for transluminal implantation in patients with aortic valve stenosis. Recent Pat Cardiovasc Drug Discov. 2012;7: 206-215.
22. Motloch LJ, Reda S, Rottlaender D, Heigert M, Hoppe UC. Transcatheter aortic valve replacement: when should it be used in aortic stenosis? Wien Med Wochenschr. 2012;162: 340-348.
23. Fernández D, Cevallos J, Brugaletta S, Martín-Yuste V, Freixa X, Andrea R, et al. Percutaneous transcatheter aortic valve implantation: present and future perspective. Expert Rev Med Devices. 2013;10: 185-199.
24. Yabe A, Ohkawa S, Watanabe C, Chida K, Kuboki K. Clinicopathologic study of calcified aortic valve stenosis in the aged, and evaluation of the indications for percutaneous aortic balloon valvuloplasty. J Cardiol. 2000;36:311-319. (text in Japanese with English abstract)
25. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16: 523-532.
26. Ankeny RF, Thourani VH, Weiss D, Vega JD, Tayler WR, Nerem RM, et al. Preferential activation of smad1/5/8 on the fibrosa endothelium in calcified human aortic valves-association with low BMP antagonists and smad6. PLoS One. 2011;6:e20969.
27. Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, Furukawa KI. TNF-a accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther. 2011;337: 16-23.
28. Nomura A, Seya K, Yu Z, Daitoku K, Motomura S, Furukawa KI. CD34-negative mesenchymal stem-like cells may act as the cellular origin of human aortic valve calcification. Biochem Biophys Res Commun. 2013;440: 780-785.
29. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, et al. Calcific aortic valve disease: not simply a degenerative process. Circulation. 2011;124: 1783-1789.
30. Lester W, Rosenthal A, Granton B, Gotlieb AI. Porcine mitral valve interstitial cells in culture. Lab Invest. 1988;59: 710-719.
31. Seya K, Yu Z, Kanemaru K, Daitoku K, Akemoto Y, Shibuya H, et al. Contribution of bone morphogenetic protein-2 to aortic valve calcification in aged rat. J Pharmacol Sci. 2011;115: 8-14.
32. Kaden JJ, Dempfle CE, Grobholz R, Tran HT, Kiliç R, Sarikoç A, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis. 2003;170: 205-211.
33. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. New Eng J Med. 2013;368: 503-512.
34. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, et al. Multilineage potential of cells from the artery wall. Circulation. 2003;108: 2505-2510.
35. Rusanescu G, Weissleder R, Aikawa E. Notch signaling in cardiovascular disease and calcification. Curr Cardiol Rev. 2008;4: 148-156.
36. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116: 2841-2850.
37. Linefsky JP, O'Brien KD, Katz R, de Boer IH, Barasch E, Jenny NS, et al. Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol. 2011;58: 291-297.
38. Lin CS, Ning H, Lin G, Lue TF. Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy. 2012;14: 1159-1163.
39. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276: 71-74.
40. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147.
41. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells. 2007;25: 750-760.
42. Segawa Y, Muneta T, Makino H, Nimura A, Mochizuki T, Ju YJ, et al. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles. J Orthop Res. 2009;27: 435-441.
43. Frenette PS, Pinho S, Lucas D, Scheiermann C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol. 2013;31: 285-316.
44. Chen JH, Yip CY, Sone ED, Simmons CA. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol. 2009;174: 1109-1119.
45. Parolari A, Loardi C, Mussoni L, Cavallotti L, Camera M, Biglioli P, et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiothorac Surg. 2009;35: 493-504.
46. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Med. 2010;16: 1400-1406.
47. Asari T, Furukawa KI, Tanaka S, Kudo H, Mizukami H, Ono A, et al. Mesenchymal stem cell isolation and characterization from human spinal ligaments. Biochem Biophys Res Commun. 2012;417: 1193-1199.
48. Chin S, Furukawa KI, Ono A, Asari T, Harada Y, Wada K, et al. Immunohistochemical localization of mesenchymal stem cells in ossified human spinal ligaments. Biochem Biophys Res Commun. 2013;436: 698-704.
49. Nelson ER, Wong VW, Krebsbach PH, Wang SC, Levi B. Heterotopic ossification following burn injury: the role of stem cells. J Burn Care Res. 2012;33: 463-470.
50. Rui YF, Lui PP, Chan LS. Does erroneous differentiation of tendon-derived stem cells contribute to the pathogenesis of calcifying tendinopathy? Chin Med J. 2011;124: 606-610.
51. Visconti RP, Ebihara Y, LaRue AC, Fleming PA, McQuinn TC, Masuya M, et al. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res. 2006;98: 690-696.
52. Togashi M, Tamura K, Masuda Y, Fukuda Y. Comparative study of calcified changes in aortic valvular diseases. J Nippon Med Sch. 2008;75: 138-145.
53. Suda RK, Billings PC, Egan KP, Kim J-H, McCarrick-Walmsley R, Glaser DL, et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009;27: 2209-2219.
54. Egan KP, Kim JH, Mohler ER 3rd, Pignolo RJ. Role for circulating osteogenic precursor (COP) cells in aortic valvular disease. Arterioscler Thromb Vasc Biol. 2011;31: 2965-2971.
55. Gössl M, Khosla S, Zhang X, Higano N, Jordan KL, Loeffler D, et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis, J Am Coll Cardiol. 2012;60: 1945-1953.
56. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437: 270-274.
57. Alfieri CM, Cheek J, Chakraborty SM, Yutzey KE. Wnt signaling in heart valve development and osteogenic gene induction. Dev Biol. 2010;338;127-135.
58. Rajamannan NM. Oxidative-Mechanical Stress Signals Stem Cell Niche Mediated Lrp5 Osteogenesis in eNOS null mice. J Cell Biochem. 2012;113: 1623-1634.
59. Di Lullo L, Floccari F, Santoboni A, Barbera V, Rivera RF, Granata A, et al. Progression of cardiac valve calcification and decline of renal function in CKD patients. J Nephrol. 2013;26: 739-744.
60. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20: 381-387.
61. Kahnooj M, Masoomi M, Naderinasab A, Zaeem A, Sheikhvatan M. Relationship between Calcium-Phosphorus Product and Severity of Valvular Heart Insufficiency in Patients Undergoing Chronic Hemodialysis. J Tehran Heart Cent. 2010;5: 78-82.
62. Capoulade R, Clavel MA, Dumesnil JG, Chan KL, Teo KK, Tam JW, et al. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol. 2012;60: 216-223.
63. Nadlonek NA, Lee JH, Weyant MJ, Meng X, Fullerton DA. ox-LDL induces PiT-1 expression in human aortic valve interstitial cells. J Surg Res. 2013;S0022-S4804.
64. Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, et al. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res. 2006;21: 674-683.
65. Jian B, Narula N, Li QY, Mohler ER 3rd, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg. 2003;75: 457-465.
66. Yip CYY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 2009;936-942.
67. Zebboudj AF, Imura M, Boström K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem. 2002;277: 4388-4394.
68. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100: 593-603.
69. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res. 2008;122: 411-417.
70. Rennenberg RJ, de Leeuw PW, Kessels AG, Schurgers LJ, Vermeer C, van Engelshoven JM, et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest. 2010;40: 344-349.
71. Ing SW, Mohler III ER, Putt ME, Torigian D, Leonard MB. Correlates of valvular ossification in patients with aortic valve stenosis. Clin Transl Sci. 2009;2: 431-435.
72. Lerner RG, Aronow WS, Sekhri A, Palaniswamy C, Ahn C, Singh T, et al. Warfarin use and the risk of valvular calcification. J Thrombo Haemost. 2009;7: 2023-2027.
73. Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoç A, Kiliç R, et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol. 2004;36: 57-66.
74. Weiss RM, Lund DD, Chu Y, Brooks RM, Zimmerman KA, El Accaoui R, et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. PLoS One. 2013;8:e65201.
75. Zhou S, Fang X, Xin H, Li W, Qiu H, Guan S. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. PLoS One. 2013;8:e68987.
76. Richards J, El-Hamamsy I, Chen S, Sarang Z, Sarathchandra P, Yacoub MH, et al. Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol. 2013;182: 1922-1931.
77. Kennedy JA, Hua X, Mishra K, Murphy GA, Rosenkranz AC, Horowitz JD. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors. Eur J Pharmacol. 2009;602: 28-35.
78. Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009;29: 761-766.
79. Al-Aly Z, Shao J-S, Lai C-F, Huang E, Cai J, Behrmann A, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr/mice. Arterioscler Thromb Vasc Biol. 2007;27: 2589-2596.
80. Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol. 2001;53: 557-569.
81. Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H, et al. Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie. 2013;68: 689-694.
82. Mathieu P, Voisine P, Pépin A, Shetty R, Savard N, Dagenais F. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J Heart Valve Dis. 2005;14: 353-357.
83. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER 3rd, et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg. 2007;83: 946-953.
84. Narisawa S, Harmey D, Yadav MC, O'Neill WC, Hoylaerts MF, Millán JL. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res. 2007;22: 1700-1710.